We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$53.7B
1-Year Est. Return
29.47%
This Fund
S&P 500
This Quarter
Est. Return
-3.67%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
–
AUM
$40.3B
AUM Growth
-$1.82B
(-4.3%)
Cap. Flow
+$332M
Cap. Flow
% of AUM
0.83%
Top 10 Holdings %
Top 10 Hldgs %
25.24%
Holding
2,393
New
237
Increased
785
Reduced
642
Closed
83
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$231M |
| 2 |
Gilead Sciences
GILD
|
+$113M |
| 3 |
PG&E
PCG
|
+$102M |
| 4 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$80.2M |
| 5 |
Allstate
ALL
|
+$64.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$472M |
| 2 |
AbbVie
ABBV
|
+$121M |
| 3 |
iShares MSCI USA Value Factor ETF
VLUE
|
+$69.5M |
| 4 |
Salesforce
CRM
|
+$64.3M |
| 5 |
Home Depot
HD
|
+$62.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.24% |
| 2 | Healthcare | 19.03% |
| 3 | Financials | 13.02% |
| 4 | Consumer Discretionary | 9.39% |
| 5 | Industrials | 7.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1876
Zai Lab
ZLAB
$2.1B
| $200K | ﹤0.01% |
5,850
+400
| +7% | +$17.1K |
|
|
EGRX
1877
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $200K | ﹤0.01% |
7,577
-950
| -11% | -$34.9K |
|
1878
Movado Group
MOV
$836M
| $199K | ﹤0.01% |
7,047
| – | – |
|
1879
Veru
VERU
$36M
| $199K | ﹤0.01% |
1,727
+705
| +69% | +$102K |
|
1880
Clean Energy Fuels
CLNE
$421M
| $198K | ﹤0.01% |
37,070
+8,740
| +31% | +$54.8K |
|
1881
Seres Therapeutics
MCRB
$46.6M
| $198K | ﹤0.01% |
1,539
| – | – |
|
1882
Children's Place
PLCE
$54.5M
| $198K | ﹤0.01% |
6,416
-950
| -13% | -$39.9K |
|
|
EB
1883
DELISTED
Eventbrite
EB
| $197K | ﹤0.01% |
32,470
+21,580
| +198% | +$182K |
|
|
CTEV
1884
Claritev Corp
CTEV
$389M
| $197K | ﹤0.01% |
1,724
-13
| -0.7% | -$2.15K |
|
1885
Sprinklr
CXM
$1.49B
| $196K | ﹤0.01% |
21,250
| – | – |
|
1886
Kratos Defense & Security Solutions
KTOS
$8.99B
| $196K | ﹤0.01% |
19,300
+5,450
| +39% | +$73K |
|
1887
RE/MAX Holdings
RMAX
$208M
| $194K | ﹤0.01% |
10,283
| – | – |
|
1888
Surgery Partners
SGRY
$2.04B
| $194K | ﹤0.01% |
8,310
+2,710
| +48% | +$86.5K |
|
|
CCC
1889
CCC Intelligent Solutions
CCC
$3.6B
| $193K | ﹤0.01% |
+21,220
| New | +$201K |
|
1890
Universal Insurance Holdings
UVE
$1.23B
| $193K | ﹤0.01% |
19,549
| – | – |
|
1891
OneSpan
OSPN
$576M
| $192K | ﹤0.01% |
22,349
| – | – |
|
1892
West Fraser Timber
WFG
$5.27B
| $190K | ﹤0.01% |
2,400
-1,200
| -33% | -$104K |
|
|
SUM
1893
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $190K | ﹤0.01% |
+8,075
| New | +$217K |
|
1894
Harmony Biosciences
HRMY
$2.07B
| $189K | ﹤0.01% |
4,260
+880
| +26% | +$42.9K |
|
1895
TriNet
TNET
$3.14B
| $189K | ﹤0.01% |
+2,660
| New | +$216K |
|
1896
Allegiant Air
ALGT
$2.75B
| $188K | ﹤0.01% |
2,581
| – | – |
|
1897
8x8 Inc
EGHT
$275M
| $188K | ﹤0.01% |
54,390
| – | – |
|
1898
GFL Environmental
GFL
$14.2B
| $188K | ﹤0.01% |
6,800
| – | – |
|
1899
First Financial Corp
THFF
$953M
| $188K | ﹤0.01% |
4,160
+1,940
| +87% | +$89.6K |
|
|
CCRN
1900
DELISTED
Cross Country Healthcare
CCRN
| $187K | ﹤0.01% |
6,590
+5,800
| +734% | +$149K |
|
Similar funds
SCP
Ensign Peak Advisors's Q3 2022 Portfolio in Review
As of Q3 2022, Ensign Peak Advisors held 2,393 positions worth $40.3B, down 4.3% from $42.1B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Ensign Peak Advisors's Q3 2022 filing shows 237 new, 785 increased, 642 reduced and 83 closed positions. Its largest new stake was iShares 1-3 Year Treasury Bond ETF: 975,000 shares worth $79.2M. The largest sale was Visa, an estimated $472M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.
- Ensign Peak Advisors's largest Q3 2022 buy was iShares 1-3 Year Treasury Bond ETF: 975,000 shares worth $79.2M.
- Ensign Peak Advisors added most to Mastercard in Q3 2022, an estimated $231M increase.
- Ensign Peak Advisors's biggest Q3 2022 reduction was AbbVie, cutting an estimated $121M.
- Ensign Peak Advisors fully exited Visa in Q3 2022, selling an estimated $472M.
- Ensign Peak Advisors's ten largest holdings make up 25% of its $40.3B portfolio in Q3 2022.
- Ensign Peak Advisors opened 237 new positions and closed 83 in Q3 2022.
- Ensign Peak Advisors's portfolio value fell 4.3% quarter-over-quarter to $40.3B.
Based on Ensign Peak Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.